- Home
- BDRX vs STRR Comparison
BDRX vs STRR Comparison
Compare BDRX & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- STRR
- Stock Information
- Founded
- BDRX 2000
- STRR 1985
- Country
- BDRX United Kingdom
- STRR United States
- Employees
- BDRX N/A
- STRR N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BDRX Health Care
- STRR Health Care
- Exchange
- BDRX Nasdaq
- STRR Nasdaq
- Market Cap
- BDRX 5.8M
- STRR 6.3M
- IPO Year
- BDRX N/A
- STRR N/A
- Fundamental
- Price
- BDRX $7.02
- STRR $1.98
- Analyst Decision
- BDRX
- STRR Strong Buy
- Analyst Count
- BDRX 0
- STRR 1
- Target Price
- BDRX N/A
- STRR $5.00
- AVG Volume (30 Days)
- BDRX 147.7K
- STRR 19.7K
- Earning Date
- BDRX 09-29-2025
- STRR 08-13-2025
- Dividend Yield
- BDRX N/A
- STRR N/A
- EPS Growth
- BDRX N/A
- STRR N/A
- EPS
- BDRX N/A
- STRR N/A
- Revenue
- BDRX N/A
- STRR $57,165,000.00
- Revenue This Year
- BDRX N/A
- STRR $33.64
- Revenue Next Year
- BDRX N/A
- STRR $22.87
- P/E Ratio
- BDRX N/A
- STRR N/A
- Revenue Growth
- BDRX N/A
- STRR 34.33
- 52 Week Low
- BDRX $5.85
- STRR $1.72
- 52 Week High
- BDRX $166.93
- STRR $4.74
- Technical
- Relative Strength Index (RSI)
- BDRX 31.36
- STRR 42.53
- Support Level
- BDRX $5.85
- STRR $1.95
- Resistance Level
- BDRX $8.75
- STRR $2.05
- Average True Range (ATR)
- BDRX 0.66
- STRR 0.07
- MACD
- BDRX -0.12
- STRR -0.01
- Stochastic Oscillator
- BDRX 30.92
- STRR 12.00
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.